Published in EMBO J on July 15, 1998
Measles virus spread and pathogenesis in genetically modified mice. J Virol (1998) 2.84
Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J Virol (2007) 2.82
Influenza virus matrix protein is the major driving force in virus budding. J Virol (2000) 2.49
Measles virus structural components are enriched into lipid raft microdomains: a potential cellular location for virus assembly. J Virol (2000) 2.40
Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus. J Virol (1999) 2.34
Requirements for budding of paramyxovirus simian virus 5 virus-like particles. J Virol (2002) 2.02
Strength of envelope protein interaction modulates cytopathicity of measles virus. J Virol (2002) 1.97
A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression. J Virol (2000) 1.92
Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity. J Virol (2004) 1.89
The hemagglutinin of canine distemper virus determines tropism and cytopathogenicity. J Virol (2001) 1.88
Measles virus assembly within membrane rafts. J Virol (2000) 1.65
Involvement of the cytoplasmic domain of the hemagglutinin-neuraminidase protein in assembly of the paramyxovirus simian virus 5. J Virol (1999) 1.64
Roles for the cytoplasmic tails of the fusion and hemagglutinin-neuraminidase proteins in budding of the paramyxovirus simian virus 5. J Virol (2002) 1.51
Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice. J Virol (2000) 1.48
Paramyxovirus assembly and budding: building particles that transmit infections. Int J Biochem Cell Biol (2010) 1.44
The matrix protein of Marburg virus is transported to the plasma membrane along cellular membranes: exploiting the retrograde late endosomal pathway. J Virol (2004) 1.43
Requirements for the assembly and release of Newcastle disease virus-like particles. J Virol (2006) 1.40
Measles virus matrix protein specifies apical virus release and glycoprotein sorting in epithelial cells. EMBO J (2000) 1.33
Quantitative analysis of Nipah virus proteins released as virus-like particles reveals central role for the matrix protein. Virol J (2007) 1.30
A recombinant measles vaccine virus expressing wild-type glycoproteins: consequences for viral spread and cell tropism. J Virol (1999) 1.25
The matrix protein of measles virus regulates viral RNA synthesis and assembly by interacting with the nucleocapsid protein. J Virol (2009) 1.24
Extensive syncytium formation mediated by the reovirus FAST proteins triggers apoptosis-induced membrane instability. J Virol (2005) 1.22
Association of respiratory syncytial virus M protein with viral nucleocapsids is mediated by the M2-1 protein. J Virol (2008) 1.21
In vitro and in vivo infection of neural cells by a recombinant measles virus expressing enhanced green fluorescent protein. J Virol (2000) 1.20
Consequences of Fas-mediated human dendritic cell apoptosis induced by measles virus. J Virol (2000) 1.16
MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism. Mol Ther (2011) 1.15
Measles virus spread by cell-cell contacts: uncoupling of contact-mediated receptor (CD46) downregulation from virus uptake. J Virol (1999) 1.14
Altered interaction of the matrix protein with the cytoplasmic tail of hemagglutinin modulates measles virus growth by affecting virus assembly and cell-cell fusion. J Virol (2007) 1.13
Electron cryotomography of measles virus reveals how matrix protein coats the ribonucleocapsid within intact virions. Proc Natl Acad Sci U S A (2011) 1.13
Measles virus infection of the CNS: human disease, animal models, and approaches to therapy. Med Microbiol Immunol (2010) 1.13
The morphology and composition of influenza A virus particles are not affected by low levels of M1 and M2 proteins in infected cells. J Virol (2005) 1.13
Measles virus, immune control, and persistence. FEMS Microbiol Rev (2012) 1.12
Contributions of matrix and large protein genes of the measles virus edmonston strain to growth in cultured cells as revealed by recombinant viruses. J Virol (2005) 1.12
Eukaryotic cells and their cell bodies: Cell Theory revised. Ann Bot (2004) 1.10
A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading. J Virol (2003) 1.10
RNA interference with measles virus N, P, and L mRNAs efficiently prevents and with matrix protein mRNA enhances viral transcription. J Virol (2006) 1.09
Importance of the cytoplasmic tails of the measles virus glycoproteins for fusogenic activity and the generation of recombinant measles viruses. J Virol (2002) 1.08
N-linked glycans with similar location in the fusion protein head modulate paramyxovirus fusion. J Virol (2003) 1.07
Signal peptide and helical bundle domains of virulent canine distemper virus fusion protein restrict fusogenicity. J Virol (2007) 1.05
Measles virus spreads in rat hippocampal neurons by cell-to-cell contact and in a polarized fashion. J Virol (2002) 1.04
Subacute sclerosing panencephalitis: results of the Canadian Paediatric Surveillance Program and review of the literature. BMC Pediatr (2005) 1.02
Recombinant measles viruses expressing altered hemagglutinin (H) genes: functional separation of mutations determining H antibody escape from neurovirulence. J Virol (2001) 1.00
HIV cell-to-cell transmission requires the production of infectious virus particles and does not proceed through env-mediated fusion pores. J Virol (2012) 1.00
Amino-terminal precursor sequence modulates canine distemper virus fusion protein function. J Virol (2002) 0.97
Making it to the synapse: measles virus spread in and among neurons. Curr Top Microbiol Immunol (2009) 0.96
Nyamiviridae: proposal for a new family in the order Mononegavirales. Arch Virol (2013) 0.96
Establishment of a rescue system for canine distemper virus. J Virol (2000) 0.95
Paramyxovirus glycoprotein incorporation, assembly and budding: a three way dance for infectious particle production. Viruses (2014) 0.89
Recombinant wild-type and edmonston strain measles viruses bearing heterologous H proteins: role of H protein in cell fusion and host cell specificity. J Virol (2002) 0.89
Plasticity in structural and functional interactions between the phosphoprotein and nucleoprotein of measles virus. J Biol Chem (2012) 0.88
Productive measles virus brain infection and apoptosis in CD46 transgenic mice. J Virol (2000) 0.87
Characterization of the Tupaia rhabdovirus genome reveals a long open reading frame overlapping with P and a novel gene encoding a small hydrophobic protein. J Virol (2005) 0.86
The measles virus nucleocapsid protein tail domain is dispensable for viral polymerase recruitment and activity. J Biol Chem (2013) 0.85
Nipah virion entry kinetics, composition, and conformational changes determined by enzymatic virus-like particles and new flow virometry tools. J Virol (2014) 0.85
Evidence for ubiquitin-regulated nuclear and subnuclear trafficking among Paramyxovirinae matrix proteins. PLoS Pathog (2015) 0.85
Adaptation to cell culture induces functional differences in measles virus proteins. Virol J (2008) 0.84
The measles virus fusion protein transmembrane region modulates availability of an active glycoprotein complex and fusion efficiency. J Virol (2008) 0.84
Mutant fusion proteins with enhanced fusion activity promote measles virus spread in human neuronal cells and brains of suckling hamsters. J Virol (2012) 0.84
The F gene of the Osaka-2 strain of measles virus derived from a case of subacute sclerosing panencephalitis is a major determinant of neurovirulence. J Virol (2010) 0.83
Actin filaments disruption and stabilization affect measles virus maturation by different mechanisms. Virol J (2013) 0.82
Mutational Analysis of Measles Virus Suggests Constraints on Antigenic Variation of the Glycoproteins. Cell Rep (2015) 0.82
Measles Virus: Identification in the M Protein Primary Sequence of a Potential Molecular Marker for Subacute Sclerosing Panencephalitis. Adv Virol (2015) 0.82
Matrix protein-specific IgA antibody inhibits measles virus replication by intracellular neutralization. J Virol (2011) 0.82
Mutations in the stalk region of the measles virus hemagglutinin inhibit syncytium formation but not virus entry. J Virol (2010) 0.81
A leucine residue in the C terminus of human parainfluenza virus type 3 matrix protein is essential for efficient virus-like particle and virion release. J Virol (2014) 0.81
F-actin modulates measles virus cell-cell fusion and assembly by altering the interaction between the matrix protein and the cytoplasmic tail of hemagglutinin. J Virol (2012) 0.81
Mutations affecting transcriptional termination in the p gene end of subacute sclerosing panencephalitis viruses. J Virol (2002) 0.79
Characteristics of viruses derived from nude mice with persistent measles virus infection. J Virol (2013) 0.79
Development of measles virus-based shielded oncolytic vectors: suitability of other paramyxovirus glycoproteins. Cancer Gene Ther (2013) 0.79
Efficient reovirus- and measles virus-mediated pore expansion during syncytium formation is dependent on annexin A1 and intracellular calcium. J Virol (2014) 0.78
Creation of a completely helper cell-dependent recombinant morbillivirus. J Gen Virol (2013) 0.78
Canine distemper virus matrix protein influences particle infectivity, particle composition, and envelope distribution in polarized epithelial cells and modulates virulence. J Virol (2011) 0.78
HSP90 Chaperoning in Addition to Phosphoprotein Required for Folding but Not for Supporting Enzymatic Activities of Measles and Nipah Virus L Polymerases. J Virol (2016) 0.78
Contribution of matrix, fusion, hemagglutinin, and large protein genes of the CAM-70 measles virus vaccine strain to efficient growth in chicken embryonic fibroblasts. J Virol (2009) 0.77
Constraints on the Genetic and Antigenic Variability of Measles Virus. Viruses (2016) 0.77
Nipah Virus Matrix Protein Influences Fusogenicity and Is Essential for Particle Infectivity and Stability. J Virol (2015) 0.77
Clearance of measles virus from persistently infected cells by short hairpin RNA. J Virol (2009) 0.76
Reverse genetics identifies the product of open reading frame 4 as an essential particle assembly factor of Nyamanini virus. J Virol (2013) 0.76
Modulation of Re-initiation of Measles Virus Transcription at Intergenic Regions by PXD to NTAIL Binding Strength. PLoS Pathog (2016) 0.75
Measles Virus Matrix Protein Inhibits Host Cell Transcription. PLoS One (2016) 0.75
Role of carbamazepine in the symptomatic treatment of subacute sclerosing panencephalitis: a case report and review of the literature. Case Rep Neurol Med (2013) 0.75
The structurally disordered paramyxovirus nucleocapsid protein tail domain is a regulator of the mRNA transcription gradient. Sci Adv (2017) 0.75
Homologous recombination is a force in the evolution of canine distemper virus. PLoS One (2017) 0.75
Dimerization Efficiency of Canine Distemper Virus Matrix Protein Regulates Membrane Budding Activity. J Virol (2017) 0.75
Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most Effective. Front Oncol (2017) 0.75
Rescue of measles viruses from cloned DNA. EMBO J (1995) 7.87
Virus-cell and cell-cell fusion. Annu Rev Cell Dev Biol (1996) 5.83
Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell (1988) 4.90
Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J Virol (1998) 3.27
Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology (1992) 2.89
Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J (1987) 2.67
Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease. J Virol (1993) 2.38
Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA. Cell (1994) 2.08
A viral protease-mediated cleavage of the transmembrane glycoprotein of Mason-Pfizer monkey virus can be suppressed by mutations within the matrix protein. Proc Natl Acad Sci U S A (1992) 1.83
Chimeric measles viruses with a foreign envelope. J Virol (1998) 1.75
Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein. J Virol (1997) 1.70
A transgenic mouse model for measles virus infection of the brain. Proc Natl Acad Sci U S A (1997) 1.62
Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion. J Virol (1996) 1.51
Clonal expansion of hypermutated measles virus in a SSPE brain. Virology (1993) 1.42
Subacute sclerosing panencephalitis is typically characterized by alterations in the fusion protein cytoplasmic domain of the persisting measles virus. Virology (1992) 1.39
Microscopy of internal structures of Sendai virus associated with the cytoplasmic surface of host membranes. Virology (1982) 1.36
Measles virus: conditions for the propagation and purification of infectious virus in high yield. J Virol Methods (1984) 1.35
Persistence of RNA viruses in the central nervous system. Annu Rev Microbiol (1986) 1.33
Detection of measles virus nucleoprotein mRNA in autopsied brain tissues. J Gen Virol (1995) 1.32
Interaction of Sendai viral F, HN, and M proteins with host cytoskeletal and lipid components in Sendai virus-infected BHK cells. Virology (1995) 1.27
Measles virus infections in rodents. Curr Top Microbiol Immunol (1995) 1.25
Alphavirus and flavivirus glycoproteins: structures and functions. Cell (1995) 1.10
Monkeys in measles research. Curr Top Microbiol Immunol (1995) 1.02
Immune reactive measles virus polypeptides on the cell's surface: turnover and relationship of the glycoproteins to each other and to HLA determinants. J Immunol (1981) 0.98
A regular subunit pattern seen on non-infectious Newcastle disease virus particles. J Gen Virol (1984) 0.95
Round cell variant of measles virus: spontaneous conversion from productive to cell-associated state of infection. Virology (1985) 0.90
Inhibition of measles virus budding by phenothiazines. Virology (1983) 0.89
Measles virus-induced hippocampal neurodegeneration in the mouse: a novel, subacute model for testing neuroprotective agents. Neurosci Lett (1993) 0.87
Round cell variant of measles virus: neurovirulence and pathogenesis of acute encephalitis in newborn hamsters. Virology (1986) 0.87
Fusogenic determinants of highly cytopathic subtype D Zairian isolate HIV-1 NDK. Virology (1995) 0.84
Increased brain quinolinic acid production in mice infected with a hamster neurotropic measles virus. Exp Neurol (1994) 0.82
Functional role of type I and type II interferons in antiviral defense. Science (1994) 18.92
Mice devoid of PrP are resistant to scrapie. Cell (1993) 11.46
Rescue of measles viruses from cloned DNA. EMBO J (1995) 7.87
Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J (1995) 6.94
Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J (1996) 6.66
Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature (1995) 6.13
Signals regulating hepatitis B surface antigen transcription. Nature (1983) 5.02
Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell (1988) 4.90
The nucleotide sequence complexity of avian tumor virus RNA. Proc Natl Acad Sci U S A (1974) 4.86
The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat Genet (1999) 4.77
A physical map of the Rous sarcoma virus genome. J Mol Biol (1976) 4.56
Replication strategy of human hepatitis B virus. J Virol (1987) 4.42
Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature (1996) 4.25
Mapping of biological functions on RNA of avian tumor viruses: location of regions required for transformation and determination of host range. Proc Natl Acad Sci U S A (1975) 4.01
Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J Virol (2001) 3.65
Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell (1998) 3.59
Hepatitis B virus transcription in the infected liver. EMBO J (1984) 3.44
c-jun is essential for normal mouse development and hepatogenesis. Nature (1993) 3.43
Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev (1995) 3.41
Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature (1984) 3.32
Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J Virol (1998) 3.27
One hundred base pairs of 5' flanking sequence of a vaccinia virus late gene are sufficient to temporally regulate late transcription. Proc Natl Acad Sci U S A (1985) 3.23
Measles virus editing provides an additional cysteine-rich protein. Cell (1989) 3.22
cDNA structures and regulation of two interferon-induced human Mx proteins. Mol Cell Biol (1989) 3.20
A crucial role for B cells in neuroinvasive scrapie. Nature (1998) 3.19
Localization of Q-beta maturation cistron ribosome binding site. Nat New Biol (1971) 2.91
Measles virus spread and pathogenesis in genetically modified mice. J Virol (1998) 2.84
Cloned HBV DNA causes hepatitis in chimpanzees. Nature (1982) 2.80
Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev (1992) 2.77
Ilizarov treatment of tibial nonunions with bone loss. Clin Orthop Relat Res (1989) 2.71
Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J (1987) 2.67
Structure of the FMDV translation initiation site and of the structural proteins. Nucleic Acids Res (1983) 2.58
Avian myeloblastosis virus RNA is terminally redundant: implications for the mechanism of retrovirus replication. Cell (1977) 2.55
Biased hypermutation of viral RNA genomes could be due to unwinding/modification of double-stranded RNA. Cell (1989) 2.54
Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J Neurosci (2000) 2.54
Structure and function of phage RNA. Annu Rev Biochem (1973) 2.50
The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur J Immunol (1995) 2.47
Replication of viral ribonucleic acid. IX. Properties of double-stranded RNA from Escherichia coli infected with bacteriophage MS2. J Mol Biol (1966) 2.45
PrP expression in B lymphocytes is not required for prion neuroinvasion. Nat Med (1998) 2.40
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis (2010) 2.38
Yeast mutants pleiotropically impaired in the regulation of the two glutamate dehydrogenases. Biochem Biophys Res Commun (1973) 2.37
Retracted Infectious measles virus from cloned cDNA. EMBO J (1990) 2.36
Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus. J Virol (1999) 2.34
Complement facilitates early prion pathogenesis. Nat Med (2001) 2.30
Targeted mutation of the CREB gene: compensation within the CREB/ATF family of transcription factors. Proc Natl Acad Sci U S A (1994) 2.24
New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet (1996) 2.20
Infectious hepatitis B virus from cloned DNA of known nucleotide sequence. Proc Natl Acad Sci U S A (1985) 2.20
Benzodiazepine-insensitive mice generated by targeted disruption of the gamma 2 subunit gene of gamma-aminobutyric acid type A receptors. Proc Natl Acad Sci U S A (1995) 2.19
High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene. Mol Med (1994) 2.18
Post-exposure prophylaxis after accidental prion inoculation. Lancet (1997) 2.15
Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science (2000) 2.15
Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment. Cell (1989) 2.14
Prion research: the next frontiers. Nature (1997) 2.13
Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. Neuron (2000) 2.13
Rescue of synthetic measles virus minireplicons: measles genomic termini direct efficient expression and propagation of a reporter gene. Virology (1995) 2.11
Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol (1995) 2.10
PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature (1997) 2.08
The absence of c-fos prevents light-induced apoptotic cell death of photoreceptors in retinal degeneration in vivo. Nat Med (1997) 2.07
Induction of the PML protein by interferons in normal and APL cells. Leukemia (1995) 2.05
No propagation of prions in mice devoid of PrP. Cell (1994) 2.02
Ammonia assimilation in Saccharomyces cerevisiae as mediated by the two glutamate dehydrogenases. Evidence for the gdhA locus being a structural gene for the NADP-dependent glutamate dehydrogenase. Mol Gen Genet (1974) 2.02
Recombinant measles viruses defective for RNA editing and V protein synthesis are viable in cultured cells. Virology (1997) 2.01
Physical mapping of vaccinia virus temperature-sensitive mutations. Virology (1983) 2.00
Ureidosuccinic acid uptake in yeast and some aspects of its regulation. J Bacteriol (1972) 1.98
Preferential initiation at the second AUG of the measles virus F mRNA: a role for the long untranslated region. Virology (1995) 1.96
Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain (2004) 1.96
The nonstructural C protein is not essential for multiplication of Edmonston B strain measles virus in cultured cells. Virology (1996) 1.95
Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J Immunol (1999) 1.92
Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro. Proc Natl Acad Sci U S A (1996) 1.89
The hemagglutinin of canine distemper virus determines tropism and cytopathogenicity. J Virol (2001) 1.88
Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology (2005) 1.88
Measles virus envelope glycoproteins hetero-oligomerize in the endoplasmic reticulum. J Biol Chem (2001) 1.87
A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor. EMBO J (1998) 1.86
Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases) Brain Pathol (1995) 1.86
Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain. EMBO J (2001) 1.85
Sequence of the first 175 nucleotides from the 5' terminus of Qbeta RNA synthesized in vitro. Nature (1969) 1.84
Expression of defective measles virus genes in brain tissues of patients with subacute sclerosing panencephalitis. J Virol (1986) 1.84
Multiple viral mutations rather than host factors cause defective measles virus gene expression in a subacute sclerosing panencephalitis cell line. J Virol (1988) 1.84
Systemic therapy of myeloma xenografts by an attenuated measles virus. Blood (2001) 1.84
Lines of murine oligodendroglial precursor cells immortalized by an activated neu tyrosine kinase show distinct degrees of interaction with axons in vitro and in vivo. Eur J Neurosci (1995) 1.83
Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science (2001) 1.82
A novel expression selection approach allows precise mapping of the hepatitis B virus enhancer. Nucleic Acids Res (1985) 1.82
Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. Blood (2001) 1.82
Retracted Functional and nonfunctional measles virus matrix genes from lethal human brain infections. J Virol (1991) 1.82
Ectopic expression of prion protein (PrP) in T lymphocytes or hepatocytes of PrP knockout mice is insufficient to sustain prion replication. Proc Natl Acad Sci U S A (1999) 1.81
Host range deletion mutant of vaccinia virus defective in human cells. Virology (1981) 1.81
Expression of hepatitis B antigens with a simian virus 40 vector. J Virol (1984) 1.80
Studies on the structure and synthesis of Rous sarcoma virus RNA. Cold Spring Harb Symp Quant Biol (1975) 1.80
Prion protein expression in different species: analysis with a panel of new mAbs. Proc Natl Acad Sci U S A (1998) 1.80
Initiation sites of Rous sarcoma virus RNA-directed DNA synthesis in vitro. Nature (1976) 1.77